))
Colchicine Unveiled: A New Dawn in Cardiovascular Prevention
Manage episode 384014773 series 3393216
内容由Baptist Health提供。所有播客内容（包括剧集、图形和播客描述）均由 Baptist Health 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Join Baptist Health Miami Cardiac & Vascular Institute experts Jonathan Fialkow, M.D., FACC, Adedapo (Dapo) Iluyomade, M.D., and Sergiu Darabant, M.D. as they discuss how this development could revolutionize the approach to combating cardiometabolic diseases through targeting inflammation, and what it means for your patients.
In this enlightening episode, we delve into the groundbreaking FDA approval of colchicine for the prevention of major adverse cardiovascular events. Join us as we explore the journey of this ancient remedy, traditionally used for gout, now emerging as a promising agent in cardioprotection. We dissect the pivotal clinical trials and evidence-based data that led to this landmark decision, shedding light on colchicine's mechanism of action and its potential role in reshaping preventive cardiology.
Guests:
Jonathan Fialkow, M.D., FACC
Chief Medical Executive for Population Health, Value and Primary Care
Deputy Director of Miami Cardiac & Vascular Institute
Chief of Cardiology, Baptist Hospital
Adedapo (Dapo) Iluyomade, M.D., Preventive Cardiologist, Baptist Health Miami Cardiac & Vascular Institute
Sergiu Darabant, M.D., Cardiologist, Baptist Health Miami Cardiac & Vascular Institute
22集单集
分享
